The VANGUARD consortium is proud to join the World Health Organization in commemorating World Health Day 2024 on April 7. This year’s theme, ‘My Health, My Right,’ champions the fundamental right to health services and quality living conditions for everyone
The VANGUARD project is currently in its 52nd month of research and has made progress in all its work packages. Specifically, the research outcomes have resulted in a significant number of dissemination and communication activities, exceeding initial expectations. To date,
On January 27-28, the VANGUARD general assembly took place in Innsbruck, Austria. Nineteen participants representing the consortium’s nine project partners gathered for a two-day program consisting of project updates, planning sessions, and discussions. The meeting was kindly organized by the
A new publication on Regulatory Challenges at the Intersection of Cellular and Medical Device Therapies in Europe: The Case of the Bioartificial Pancreas in Law, Technology and Humans. Abstract Regenerative medicine solutions for type 1 diabetes are a rapidly developing
VANGUARD partners have published a publication titled The Relevance of Advanced Therapy Medicinal Products in the Field of Transplantation and the Need for Academic Research Access: Overcoming Bottlenecks and Claiming a New Time as part of the Transplant International special
As part of the Transplant International special issue on The Future of Beta Cells Replacement in the Era of Regenerative Medicine and Organ Bioengineering, VANGUARD partners published a review article on Clinical Translation of Bio-Artificial Pancreas Therapies: Ethical, Legal and
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 874700